Search results for: 'diseas tech eu'

15 Apr 2025  |  Europe  |  Market Research

CO2 Emissions Life Cycle in the Hydrogen ICE Truck Sector, EU, 2024–2040

Clean H2 Production Sources and the Adoption of H2 ICE as an Intermediate Solution Will Drive Transformational Growth by Significantly Reducing CO2 Emissions

Infographics

×

In this study, Frost & Sullivan offers a comprehensive exploration of the carbon dioxide (CO2) trail of a hydrogen ICE truck (H2 ICE) by investigating the carbon emission implications, focusing on hydrogen as a prospective fuel for the trucking industry in 3 countries within the European Union—France, Germany, and Spain. The analysis begins with th...

22 Oct 2024  |  Global  |  Technology Research

Top 10 Electronics Technologies in the Retail Industry

Innovation and Adoption of Advanced Electronics Will Enhance the Customer Buying Experience

Infographics

×

The retail industry has witnessed a fundamental shift from its conventional operations, mainly due to advancements in technologies, changing consumer preferences, and a high focus on enhanced efficiency. Advanced electronics technologies, such as AR/VR, IoT, and RFID, are increasingly being integrated into retail environments to enhance the shoppin...

This research service tracks the key trends in the EU digestive health ingredients markets, while also quantifying the markets in terms of revenue and unit shipment. Key companies and their position in their relevant market segments is analyzed. It provides revenue forecasts at a total market and segment level, from 2009 to 2015. It also includes i...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

Research Scope: Political, Economic, Social, Technology, Legal, and Environment Analysis Geographic Scope: US, UK, EU What makes this study unique? It analyses the changing political, economic, social, technological, legal, and environment across the US, UK, EU, while highlighting the implications of these changes. Key Questions Answered: What i...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...